Latest News

Page 18 of 28« First...10...1617181920...Last »

January 31, 2014

The Monster Behind The Door

Posted in: Latest News

Audio/Visual Presentation Now Online Fear of the unknown, and of being alone, are the worst of all fears, and, therefore, the biggest challenges in coping with progressive vision loss. Conquering those fears can open doors of opportunities never thought possible. As this month’s International Low Vision Support Group presenter, Dan Roberts, introduces his childhood monster
read more »

January 29, 2014

Seniors With Wet AMD Now Less Likely to Need Long-Term Care

Posted in: Latest News, Research and Developments

Researchers have looked at a sample population of senior adults newly diagnosed with wet age-related macular degeneration (exudative, or neovascular, AMD) and found that those who received either Lucentis or Avastin injections* were 19% less likely to be admitted to a long-term care facility during the follow-up period. The reason? The introduction of anti-VEGF therapy
read more »

January 29, 2014

U-M Kellogg Eye Center performs first two retinal prosthesis implants in U.S. since FDA approval

Posted in: Latest News, Therapies, Treatments, and Procedures

Kellogg retina surgeons implant Argus II Retinal Prosthesis, or ‘bionic eye,’ for two patients with end-stage retinitis pigmentosa ANN ARBOR, Mich. — Retina surgeons at the University of Michigan Kellogg Eye Center have performed the first – and second – surgeries in the United States to implant an artificial retina, or “bionic eye,” since the U.S. Food and
read more »

January 18, 2014

Findings Help Predict AMD Advancement

Posted in: Latest News, Research and Developments

A 10-year follow-up study of participants in the original AREDS trial has been completed. The Age-Related Eye Disease Study Research Group revealed new statistics on the risk and rate of progression from early to advanced age-related macular degeneration (AMD). Participants aged 55 to 80 years with no AMD or AMD of varying severity were followed
read more »

January 16, 2014

Choroideremia Gene Therapy Showing Promise

Posted in: Latest News, Research and Developments

Researchers at Oxford University have reported successful findings from their Phase 1/2 clinical testing of the CHM gene for treatment of choroideremia. Choroideremia is a rare disease affecting mostly males that leads to blindness. In the multicentre clinical trial, six male patients (aged 35—63 years) all showed improvement after replacement of the malfunctioning gene. The
read more »

January 15, 2014

PBA Shortens Its Name, Expands Its Reach

Posted in: Latest News

In a press release today, Prevent Blindness America, the nation’s oldest eye health and safety organization, announces that it has revised its name to “Prevent Blindness”. This action acknowledges that the organization recognizes a growing global reliance on the Internet for information about eye health. Future articles in this section will, therefore, pertain not only
read more »

January 7, 2014

There’s so much more in life to see

Posted in: Eye Conditions, Latest News

January is National Glaucoma Month The best years are yet to come. With more free time, you can set your sights on wonderful places to go and people to see. Just make sure you keep an eye on glaucoma. Glaucoma is a group of diseases that damages the eye’s optic nerve, which carries visual signals
read more »

January 6, 2014

More Reason to Quit Cigarettes

Posted in: Health and Nutrition, Latest News, Research and Developments

A new study has found further evidence of the risk of cataracts caused by cigarette smoking. A report published January 2, 2014 in JAMA revealed that smoking more than 15 cigarettes per day was associated with a 42% higher likelihood of cataract development compared to those have never smoked. In people who quit smoking for
read more »

December 17, 2013

Legislation Works Toward Medicare Reimbursement for Low Vision Devices

Posted in: Latest News

New legislation may establish a nationwide demonstration project to evaluate the fiscal impact of Medicare coverage for low vision devices. H.R. 3749, introduced by Reps. Carolyn Maloney (D-NY) and Gus Bilirakis (R-FL), would initiate the five-year demo project. It is intended to provide data that would assist Congress in making changes to the current Medicare
read more »

December 11, 2013

Time Between Lucentis and Eylea Treatments Found To Be Similar

Posted in: Latest News, Therapies, Treatments, and Procedures

The principal difference between the two leading FDA-approved anti-VEGF drugs, Eylea and Lucentis for treatment of retinal hemorrhage has been accepted as the difference in length of time between injections. A new study, however, found no significant difference in injection scheduling between the drugs. The overall mean days between injections differed by only 1.8 days
read more »

Page 18 of 28« First...10...1617181920...Last »

Custom Wordpress design and web development by Jeff Roberts Web Design

WP-Backgrounds by InoPlugs Web Design and Juwelier Schönmann